Notice of Intent to Publish a Funding Opportunity Announcement for New Investigators to Promote Workforce Diversity in Genomics and other Health-Related Research (R01 Clinical Trial Optional)
Notice Number:
NOT-HG-21-024

Key Dates

Release Date:
March 31, 2021
Estimated Publication Date of Funding Opportunity Announcement:
April 02, 2021
First Estimated Application Due Date:
August 03, 2021
Earliest Estimated Award Date:
April 01, 2022
Earliest Estimated Start Date:
April 30, 2022
Related Announcements

PAR-19-222 - Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)

Issued by

National Human Genome Research Institute (NHGRI)

Purpose

The purpose of this Notice is to alert the community that NHGRI plans to publish a Funding Opportunity Announcement (FOA) for New Investigators to Promote Workforce Diversity in Genomics and other Health-Related Research (R01 Clinical Trial Optional). This program is intended to provide funds for New Investigators from diverse backgrounds, including those from groups underrepresented in the biomedical sciences, to pursue independent research within the mission of the participating institutes and centers. .

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.

The FOA is expected to be published in Spring of 2021. Applications are expected to be accepted in the beginning of August 2021 for FY22 funding. .

This FOA will utilize the R01. Details of the planned FOA are provided below.

Research Initiative Details

Research Initiative Details

This program will support research performed by investigators who are from diverse backgrounds, including those from underrepresented groups (as described in the NIH Diversity Statement NOT-OD-20-031). The goal is to enhance the diversity of R01 funded investigators. Eligibility criteria includes applicants who meet the NIH criteria for New Investigator ,( https://grants.nih.gov/policy/early-investigators/index.htm), including Early Stage Investigators, a subset of New Investigators. New Investigators are investigators who have not previously competed successfully for substantial, independent funding from NIH. Early Stage Investigators are investigators who have completed their terminal research degree or end of post-graduate clinical training, whichever date is later, within the past 10 years and who have not previously competed successfully as PD/PI for a substantial NIH independent research award.

Applicants to NHGRI may propose any research topic suitable for an R01 within the NHGRI mission, as described on the NHGRI website for the Division of Genome Sciences, the Division of Genomic Medicine, and the Ethical, Legal and Social Implications Research Program..

If other ICs sign on, they will announce their criteria.

Funding Information
Estimated Total Funding

Estimated NHGRI Total Funding: $5.25M

Expected Number of Awards

Expected Number of NHGRI Awards: 5-7 awards/year for each of 3 years

Estimated Award Ceiling

Estimated NHGRI Award Ceiling: $500K Direct Cost limit

Primary CFDA Numbers

93.172

Anticipated Eligible Organizations
Public/State Controlled Institution of Higher Education
Private Institution of Higher Education
Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education)
Small Business
For-Profit Organization (Other than Small Business)
State Government
Indian/Native American Tribal Government (Federally Recognized)
County governments
Independent school districts
Public housing authorities/Indian housing authorities
Indian/Native American Tribally Designated Organization (Native American tribal organizations (other than Federally recognized tribal governments)
Eligible Agencies of the Federal Government
U.S. Territory or Possession
Regional Organization

Applications are not being solicited at this time.

Inquiries

Please direct all inquiries to:

National Human Genome Research Institute (NHGRI):

Jyoti Dayal, M.S.
301-480-2307
jyotig@nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices